Inflexion

Inflexion is delighted to announce that it supported 60 acquisitions for its portfolio across 12 countries and six continents in 2024, helping to drive value and accelerate sustainable growth in the UK and internationally. The M&A represents a combined enterprise value of £900m and equates to acquired revenue of £450m. Acquisitive growth has been a key value acceleration strategy for Inflexion since inception, with over 500 completed in the last 25 years and a fifth of them taking place internationally across more than 30 countries. 🌎 ➡️ Read more: https://lnkd.in/eQMZj4TC #BackingAmbition #AcceleratingGrowth

Artificial intelligence and advanced data analytics are revolutionising sales processes, enabling companies to drive #efficiency, boost #productivity, and improve #conversion rates. Discover how Inflexion is working with its portfolio companies to transform their #commercial and #sales strategies with #data and #AI here: https://lnkd.in/dWZJZgvP #BackingAmbition #AcceleratingGrowth CNX Therapeutics Ada Pham Jan Beitner, PhD Jeremy D. Rory Jackson

🎙 New Inflexion point podcast episode out now! 🎙 The latest Inflexion point podcast episode features our portfolio company Medik8, a premium, science-backed #skincare brand, which has gained global acclaim for its results-led approach. In this episode, Medik8 founder Elliot Isaacs and Inflexion's Head of Consumer Tom Pemberton speak to Tim Smallbone about how Elliot formed the idea for the business in the back of his dad's pharmacy, the importance of a scientific and results-led approach, the development of their flagship product; crystal retinal, and what really sets Medik8 apart from the competition. ⚡ 🎧 New episode found here: https://pod.fo/e/28f4c6 🎧 Our previous podcasts which you can listen and subscribe to here: https://lnkd.in/ez5FqpzE #BackingAmbition #AcceleratingGrowth

#Pharmaceuticals companies have long relied on services and firms to support them with innovative products and offerings. In today’s market, the winners will be the providers which can help to optimise #recruitment, streamline operations and overlay #digital enhancements. 🩺 Discover insights from Matthew McCarty, a specialist in advising Life Science Technology businesses, as he explores the increasingly complex and ever-evolving nature of the sector. He also examines current challenges and opportunities and explains how the right private equity firm can support #pharma services and #healthcare technology businesses in achieving success. ➡️ https://lnkd.in/eq6x5Rgc #BackingAmbition #AcceleratingGrowth

Inflexion is pleased to announce that it has invested in Nodor International Limited, a collection of the largest premium darts equipment brands in the world. 🎯 Nodor’s key brands, Winmau Dartboard Company Ltd. and Red Dragon Darts, are the names behind many of the world’s most talented professionals. Inflexion will use its significant experience in scaling global brands to support the management team growing the business through geographic and channel expansion, as well as working with the team on product development and the use of #technology to enhance the customer experience. ➡️ Read more: https://lnkd.in/e2bXbQfM #BackingAmbition #AcceleratingGrowth

Relationships and experience are key to successful partnerships, with Inflexion’s track record in #compliance businesses and carve-outs helping GRC to thrive as an independent entity. 🤝 Read on to discover why Alex Dacre, Chief Executive of GRC, chose to partner with Inflexion in the carve-out of Marlowe plc's GRC assets in early 2024, with the aim of pursing an ambitious organic growth strategy through cross-selling services, launching new #software, investing in sales and marketing and M&A. ➡️ Learn more about Inflexion's experience in executing successful carve-outs here: https://lnkd.in/gweMEFEQ #BackingAmbition #AcceleratingGrowth

🎙 New Inflexion point podcast! ⚡ Coming soon: an exclusive podcast interview with the founder of pioneering #skincare business Medik8! In this episode, Elliot Isaacs speaks to Tim Smallbone about forming the idea for the business in the back of his dad’s pharmacy, the importance of a scientific and results-led approach, the development of their flagship product; crystal retinal, and what really sets Medik8 apart from the competition. Stay tuned - episode dropping next week. 🎧 In the meantime, listen to our previous podcasts and subscribe here: https://lnkd.in/e55ZcyP6 #BackingAmbition #AcceleratingGrowth #InflexionPoint

Inflexion's November Highlights have landed! Here are just a few key milestones from the past month: ⭐ We were named Best Pan-European Mid-Market LBO Fund at the 2024 Private Equity Exchange Awards. 👏 We announced an investment in finanzen.net GmbH the digital broker and market leading financial information portal in the #DACH region. 🍽️ We hosted a number of impactful events including our Irish Entrepreneurs and Business Leaders dinner, a Software & Data dinner, an Industrials dinner, and a Medical Devices dinner, to name a few. 🎧 Inflexion’s David Whileman explored the benefits of minority investing with Ross Butler on the Fund Shack podcast. You can see the full highlights on the Inflexion website: https://lnkd.in/eZVy6wkH #BackingAmbition #AcceleratingGrowth #MinorityInvesting

Inflexion’s minority investment into Netherlands-based specialist secondment and #recruiting agency YER is supporting the growth of its data-driven #talent platform domestically, in the US, and in Germany. 🌎 While growing through acquisition can be transformative, it is often complex, making a partner with deep experience incredibly valuable. Inflexion's track record of executing over 500 acquisitions for its portfolio companies, and assisting many in internationalising, provides substantial support for YER's expansion. 🚀 ➡️ Read more about how Inflexion is supporting YER to grow its footprint and resource with targeted European acquisitions here: https://lnkd.in/ef7ARnv6 #BackingAmbition #AcceleratingGrowth #MinorityInvesting

Great to see David Whileman, Inflexion Partner and Head of Partnership Capital, exploring the benefits of minority investing in a conversation with Ross Butler on the Fund Shack podcast. 🎙️ In the episode, David shares how #minorityinvesting provides ambitious businesses and entrepreneurs with the flexible funding and resources needed to realise value and turbocharge growth, all while allowing them to maintain control. 🚀 🎧 You can listen to the episode here: https://lnkd.in/e3Q8rqwT #BackingAmbition #AcceleratingGrowth